Koers Alliqua Biomedical Inc Nasdaq
Aandelen
US0196213096
Biotechnologie & Medisch Onderzoek
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 5 4,61 |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -11 mln. -10,13 mln. | Nettowinst (verlies) 2018 | -5 mln. -4,61 mln. | EV/omzet 2017 * | - |
Nettoliquiditeiten 2017 * | - 0 | Nettoliquiditeiten 2018 * | - 0 | EV/omzet 2018 * | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 * |
-
| Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 * |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 01-10-07 |
Rick Orr
CEO | Chief Executive Officer | - | 01-12-10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 01-01-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 01-01-08 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 50,93 mld. | |
-0,56% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-7,20% | 29,18 mld. | |
+12,59% | 26,02 mld. | |
-21,51% | 18,9 mld. | |
+6,92% | 13,21 mld. | |
+24,91% | 12,17 mld. | |
+29,60% | 12,16 mld. |